KEY TAKEAWAYS
- Charles R. Schwab — co-founder and co-chairman — sold 158,613 shares at $106.35 on February 9, totaling $16.87 million, routed through a family trust near the stock's 52-week high.
- Co-chairman Bettinger sold 257,410 shares at ~$104. The Chief Banking Officer, CTO (twice), Chief Risk Officer, a board director, and head of Advisor Services all sold in the same 30-day window.
- The stock has since dropped from ~$106 to ~$90. The cluster sold at or near the multi-year peak, before a 15% decline.
One insider selling near a high is noise. Seven selling in the same month — that's a different conversation entirely. And I'd argue it's one the financial press mostly whiffed on.
What they reported
Charles R. Schwab — the man who built the discount brokerage from scratch, still holding around 40 million shares after this — dumped 158,613 shares on February 9 at $106.35 through a family trust. $16.87 million. Then Walter Bettinger, co-chairman and the former CEO who ran the place through the TD Ameritrade integration nightmare, sold 257,410 shares on February 3–4 at roughly $104. Another ~$26.7 million out the door. And it keeps going. Chief Banking Officer Paul Woolway, 22,010 shares at $94.97. CTO Dennis Howard, 27,903 shares at $95.02 on February 25 — and then another 10,108 shares at $94.60 on March 3, like once wasn't enough. Director Stephen Ellis, 10,725 shares at $96.57. Chief Risk Officer Nigel Murtagh, 7,203 shares at $94.61. Jonathan Beatty — head of Advisor Services — 2,030 shares at $95.30.
Total across the cluster? North of $50 million in aggregate insider exits inside roughly 30 days. All of them above $94. The stock closed at $90.88 on May 15.
Beat or miss
This isn't an earnings report — no consensus to beat here. But the market context matters. Q4 2025 results on January 21 were legitimately strong: record revenue of $6.34 billion, net interest margin recovering to 2.90%, TD Ameritrade integration finally declared complete, UBS slapping a $125 price target on the name. The analyst narrative in February was unambiguously bullish. That's precisely when seven insiders decided they'd had enough.
What the filings actually reveal
The party line on insider selling is always the same. Diversification. Estate planning. Pre-scheduled 10b5-1 plans. And sure — some of these probably were. But the diversification explanation makes reasonable sense for one or two executives. It strains credibility when it applies simultaneously to the founder, the co-chairman, the head of banking, the head of technology, the chief risk officer, a board director, and the head of advisory services. That's not diversification. That's a consensus.
Which brings me to the angle nobody covered. Look at whose titles are on the sell list. The Chief Risk Officer sold. The Chief Banking Officer sold. The CTO sold twice. These aren't passive board members cleaning up legacy equity grants. These are the three executives with the deepest day-to-day visibility into Schwab's core vulnerabilities — specifically the rate sensitivity of its net interest margin, deposit stability as the Fed resumes cutting, and the ongoing technology cost burn from integrating TD Ameritrade's platforms. When those three people sell simultaneously near all-time highs, the "just diversifying" framing doesn't hold up.
Schwab faces two structural headwinds the bullish narrative glosses over. As the Fed cuts rates, net interest margin compresses — the same NIM recovery everyone celebrated in late 2025 runs in reverse in a cutting cycle, because the business model depends on the spread between client cash yields and what Schwab pays on deposits. Second: Robinhood and Interactive Brokers are eating into the active trading segment with options, crypto, and margin product development that Schwab is scrambling to match. The Chief Risk Officer models both scenarios. He sold at $94.61. Think about that for a second.
What it means for the stock in plain terms
The stock fell 15% from where the cluster sold. Not proof. Correlation, not causation — the broader market had a rough patch through April. But the pattern still deserved more analytical weight than it got.
The business isn't broken. $12.61 trillion in client assets isn't a mirage, 10.3 million daily average trades aren't a fluke, and the NIM recovery is real. But the February price — trading near 20x forward earnings on a balance sheet still exposed to rate cuts and a competitive trading environment — had already priced in most of that recovery. The seven people who understand that balance sheet most intimately all concluded February was the moment to reduce. Not when the stock was beaten down. Not after a bad quarter. At peak optimism. That asymmetry is the thing worth paying attention to, not the dollar amounts.
The one thing beginners should take away
Cluster selling by operationally-informed executives at multi-year highs during peak analyst optimism is one of the more reliable warning signals retail investors can actually access without any privileged information. You don't need to know their specific reasons. When the people running the riskiest parts of a company all choose the same narrow window to reduce exposure, that collective judgment about risk/reward is worth more than a one-paragraph mention under "routine insider activity." The stock dropped 15%. Whether that's coincidence or not, the pattern deserved a harder look than it got.